Breathing Easy – Eric Allyn, former Chairman of Welch Allyn, joins the Board of Health Care Originals
Health Care Originals (HCO), the award-winning digital health startup rocking Upstate NY, has now joined forces with healthcare guru, Eric Allyn!
Eric Allyn is the former Chairman of the Board of Welch Allyn, Inc, which was sold to Hill Rom in 2015. He’s also the founder and managing partner of two private investment funds, serves as chairman of the investment committee of a $90M private foundation, is managing partner of the Allyn Family Office, and serves on the board of directors of many organizations, including GOJO (makers of Purell), Pharm-Tech Industries, Auburn Community Hospital (former Chairman), and Healthcare Trustees of NYS (Chairman).
“I’m thrilled to join the Board of Directors of HCO. I have known the team for a few years, and have been impressed with their innovation, technology and capital efficiency. They have brought their first product to market, early feedback is very positive, and have successfully engaged a number of commercial contracts.”
Allyn led Welch Allyn, a 100+ year old, $700M manufacturer of Medical Devices that employs 2,650 world-wide. Welch Allyn was instrumental in bringing telemetry to the physician’s office, and transitioning certain levels of care from hospitals to the physician’s office.
“I see HCO’s platform technology as central to the paradigm shift that is occurring and must occur in healthcare – one in which individuality of disease and medication-response are recognized, and where consumers have the power to understand and sustainably change behavior for better health through objective data and insights. I’m looking forward to helping HCO as they grow,” added Allyn.
HCO is a leading digital health startup, integrating IoT technologies to empower everyone through improved understanding and management of their health and medical conditions. The Rochester-based company was named one of the Top 4 Medical IoT technologies in the world in 2017, winner of WT’s Innovation World Cup in 2016 and termed Breakthrough Innovation by hp TechVentures. HCO’s current wearable solutions are optimized for respiratory system applications, providing revolutionary, actionable insight into illnesses like asthma and COPD, respiratory syndromes, research, health & safety and competitive sports. HCO is also a resident company of the Johnson & Johnson Innovation, JLABS (JLABS @ NYC) incubator, and a graduate of RIT’s Venture Creations incubator.
“HCO welcomes Eric to our board especially at this time when we are poised for growth. As a digital health startup deploying our purpose-built, IoT, Edge-Computing wearable, we’re excited to have the former leader of one of the more accomplished Medical Device companies in the world be part of our growth process. Over the last few years of getting to know Eric, we’ve become convinced that our visions for healthcare are aligned, and feel confident that he will be a great resource when navigating the growth challenges ahead strategically,” said Jared Dwarika, Co-Founder of HCO.
Keith Wilson, Managing Partner of Cranberry Capital, and Director of HCO echoed these sentiments. “The team has done a great job of commercializing their platform technology, bringing different use cases to market, and raising awareness of the significant positive impact they can make for those with chronic respiratory disease and their caregivers. I’m looking forward to adding Eric’s insight and guidance to our growth strategy.”
